Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography.
about
Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy.Topical nepafenac in treatment of acute central serous chorioretinopathy.Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy.Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results.Molecular contrast optical coherence tomography: a review.Transpupillary thermotherapy for atypical central serous chorioretinopathy.Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.Imaging polarimetry in central serous chorioretinopathy.Factors influencing the visual acuity of chronic central serous chorioretinopathySystem review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.Systemic factors associated with central serous chorioretinopathy in Koreans.Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy.Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.Obstructive sleep apnea and central serous chorioretinopathy.Indocyanine green angiographic findings in central serous chorioretinopathy.Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy.Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.A case of idiopathic central serous chorioretinopathy in a 12-year-old male treated with bevacizumab.Transpupillary thermotherapy for chronic central serous chorioretinopathy.Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy.Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy.Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy.Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy.
P2860
Q24794234-53ADCB3C-EDA6-40DD-B674-F156AA234200Q33195722-C09281CC-B5BC-49A7-8665-DE8074DF32C4Q33391138-A5E76EEB-9C48-4928-8AED-6999643E1BF9Q33597082-3D769702-2B82-44C9-A890-3217AC5B4FCFQ33705962-76DA9392-F8D0-4E3A-88F1-348715E05CB5Q33899231-D8F75029-12E0-4CEB-8C08-3496005B841DQ33996055-E271E6B6-A41F-4081-BA65-388CC1143812Q34131500-30EF452C-1892-4651-A4A8-762646F09E33Q34158234-5C42BB08-7719-422A-9863-CFA1BD324858Q34325619-091C366F-6105-4D4D-BD2C-AD4257E404BFQ34394791-F4C6B0DC-53C8-4720-9C07-5F5FB6C0A526Q34625686-2A4D82EE-7071-4975-A3FA-F2F2063CFE5AQ34695063-A378F3F9-B41A-4599-8328-10A74403852AQ35209632-FA0F13AF-352A-41BB-BAC7-AB6F88B40E4CQ35582953-4C2C3ECD-7895-40AA-BF8D-50A7EFDA50CEQ35782233-682346C1-7E2F-4C55-A70D-B376558F5AB4Q35826493-DD272624-1292-48E3-957A-7C161053FE53Q36128218-E4483407-E5D4-45DF-8776-3298266C04F2Q36326807-2B524446-3622-4FD9-A78A-E44467B042BAQ36339246-AE946F30-5AA1-49B8-AA61-F6E23BC2A3BFQ36342993-B63BE4A9-B869-4554-9427-CBF535EA3815Q36407625-C1038BAE-DA42-4C4A-8304-AC99D0B6D89EQ36955739-390162CF-1450-4FA1-B800-EC5B61D01646Q37233673-1882E0C3-A409-4D1F-BB6E-FD7EFE0CFB17Q39371847-A6711EA1-3647-4744-BC2B-D62775B894B4Q39677978-4B10FB47-7EF1-4452-ABD9-A6557F1DF53AQ41190093-7C838D91-51FF-4E72-8A30-C462FD91578CQ42047268-E181D8BA-AA75-4AB5-81A1-566F46170639Q42162463-C1E29799-FEAE-4D10-A161-43C651F5BBC4Q42576696-D2375577-24FB-4C8E-8A27-810535646DBFQ43129901-E6797C1C-5034-48A5-804E-430ACA28AD9EQ43171677-762DC4D7-5855-45C7-9C74-1035CA5EA74EQ45978210-D8EACBA2-F501-434F-904F-8A46821CD303Q47104599-2FCC7F6D-CE90-4BB2-AB5F-0872EDBE49CBQ48230269-A4D76445-C9DB-4E41-A3AA-53F942199210Q49237447-97E563D1-4EC4-47E3-AC20-BB350FE6C2F5Q50119311-95F49F05-2406-4BE9-9B55-54A2151C91FEQ50224467-2CF10F62-1638-4069-A095-4AB4BE96CCECQ50531998-2DA7FFF8-BD20-4654-B64E-9F10A926F703Q51940763-A312D443-C978-4793-9E1E-AF1667F5BA4B
P2860
Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@en
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@nl
type
label
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@en
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@nl
prefLabel
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@en
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@nl
P2093
P1433
P1476
Long-term follow-up of idiopat ...... hy by fluorescein angiography.
@en
P2093
P304
P356
10.1016/S0161-6420(89)32810-7
P577
1989-06-01T00:00:00Z